findings in psychology in this preregistered study of 300 preschool children. Well-done study with a 4 year follow up. The language gains either faded or the control group caught up.
journals.sagepub.com/doi/full/10....
findings in psychology in this preregistered study of 300 preschool children. Well-done study with a 4 year follow up. The language gains either faded or the control group caught up.
journals.sagepub.com/doi/full/10....
www.mededportal.org/doi/10.15766...
www.mededportal.org/doi/10.15766...
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
ALLE andre kombinasjonar av utval (gutar, jenter, alle) og indikatorar gav ikkje-signifikante resultat.
ALLE andre kombinasjonar av utval (gutar, jenter, alle) og indikatorar gav ikkje-signifikante resultat.
www.mededportal.org/doi/10.15766...
www.mededportal.org/doi/10.15766...
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024
🤔What percentage of pancreatic adenocarcinoma cases typically express Claudin 18.2?
1) 30%
2) 50%
3) 70%
4) 90%
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024
🤔What percentage of pancreatic adenocarcinoma cases typically express Claudin 18.2?
1) 30%
2) 50%
3) 70%
4) 90%
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024
www.jstor.org/stable/2685694
www.jstor.org/stable/2685694
Können Online-Self-Assessments (OSA) auch während des Bachelorstudiums wirksam sein?
In einer Pretest–Posttest-Studie (N = 18) unter Psychologie-Studierenden zeigten sich nach der Durchführung eines OSA statistisch signifikante Zuwächse in Motivation und Entscheidungsintention.
Können Online-Self-Assessments (OSA) auch während des Bachelorstudiums wirksam sein?
In einer Pretest–Posttest-Studie (N = 18) unter Psychologie-Studierenden zeigten sich nach der Durchführung eines OSA statistisch signifikante Zuwächse in Motivation und Entscheidungsintention.
>10 = large
5-10 = moderate
2-5 = small but sometimes important
<2 = inconclusive
>10 = large
5-10 = moderate
2-5 = small but sometimes important
<2 = inconclusive
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024
Per INAVO120 data in ET-refractory, PIK3CA+ HR+ la/mBC, adding inavolisib to palbociclib + fulvestrant improved mPFS to:
9 months
12 months
15 months
18 months
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024
Per INAVO120 data in ET-refractory, PIK3CA+ HR+ la/mBC, adding inavolisib to palbociclib + fulvestrant improved mPFS to:
9 months
12 months
15 months
18 months
👉🏽 Free CME 🔗 integrityce.com/TBT2024
🧐 Which of the following would you select for a 78-year-old man w/ mPDAC (CLDN18.2, 45%; MSS; gBRCA WT) and disease progression after gemcitabine/abraxane❓
1) FOLFIRINOX
2) Regorafenib trial
3) CLDN18.2 BiTe trial
4) Pembrolizumab
👉🏽 Free CME 🔗 integrityce.com/TBT2024
🧐 Which of the following would you select for a 78-year-old man w/ mPDAC (CLDN18.2, 45%; MSS; gBRCA WT) and disease progression after gemcitabine/abraxane❓
1) FOLFIRINOX
2) Regorafenib trial
3) CLDN18.2 BiTe trial
4) Pembrolizumab